Global Medical REIT

GMRE

Market cap $476M

Global Medical REIT offers a diversified, granular healthcare property portfolio with 95.2% occupancy and an average remaining lease term of 5.3 years. GMRE has proactively extended and staggered its debt maturities, raised $50M in Series B preferred equity, and improved balance sheet flexibility. The Series A Preferred Shares yield 7.7%, are past call, and are unlikely to be redeemed soon given current rates and refinancing costs.

Global Medical REIT offers a compelling value proposition, with an 8.9% dividend yield and a forward P/FFO of 8.3. GMRE's diversified healthcare portfolio, 95%+ occupancy, and 2.1% annual rent escalators support steady cash flows and modest growth. Management's proactive debt restructuring extends maturities, mitigating refinancing risk.

Active investors have an advantage in the REIT sector. Individual REITs often get mispriced, resulting in opportunities to earn alpha-rich returns. We highlight a clear example of that.

Global Medical REIT is rated a buy, driven by strong AFFO growth, robust dividend coverage, and sector tailwinds. GMRE redeploys capital into higher cap-rate assets, maintains low tenant concentration risk, and benefits from geographic diversification including presence in high-growth regions like Texas and Florida. Despite elevated leverage (D/E 1.50), GMRE's forward P/FFO of 8.6 is 35% below sector average, suggesting undervaluation.

We are in the midst of the biggest retail sales period of the year. Yet, investors are skeptical about bargains in the stock market. Buy a bigger income stream at cheaper prices. We discuss our top defensive picks with up to 8% yields.

BETHESDA, Md.--(BUSINESS WIRE)--Global Medical REIT Inc. (NYSE: GMRE) (the “Company” or “GMRE”) today announced that Ronald Marston has notified the Board of Directors (the “Board”) that he plans to retire as a member of the Board at the end of his current term and that the Board has declared the Company's 2025 fourth quarter common and preferred dividends. Ronald Marston's Retirement from Board of Directors Mr. Marston has served on the Board since 2015 as an independent director and at differ.

Global Medical REIT Inc. has launched its 8.00% Series B Cumulative Redeemable Preferred Stock GMRE.PR.B, targeting high-yield seeking investors. GMRE-B offers a high yield but is considered highly speculative, with no credit rating and a risk profile similar to Single-B rated debt. Recent red flags for GMRE include a reverse stock split, a dividend cut, and a debt-heavy capital structure, warranting extra caution for investors.

I invest most of my capital in REITs. Even then, I'm bearish on a lot of them. This is a sector in which you need to be very selective to succeed.

BETHESDA, Md.--(BUSINESS WIRE)--Global Medical REIT Inc. (NYSE:GMRE) (the “Company”) today announced the pricing of the underwritten public offering of 2,000,000 shares of its 8.00% Series B Cumulative Redeemable Preferred Stock, $0.001 par value per share (“Series B Preferred Stock”). The Series B Preferred Stock has an initial liquidation preference of $25.00 per share. The offering is expected to close on November 20, 2025, subject to customary closing conditions. The Company expects to rece.

BETHESDA, Md.--(BUSINESS WIRE)--Global Medical REIT Inc. (NYSE:GMRE) (the “Company”) today announced the commencement of an underwritten public offering of shares of its Series B Cumulative Redeemable Preferred Stock, $0.001 par value per share (“Series B Preferred Stock”), subject to market and other conditions. The Company expects to grant the underwriters a 30-day option to purchase additional shares of Series B Preferred Stock to cover over-allotments, if any. The Company intends to use the.